Biotage AB and Shanghai Chempartner Co., Ltd. sign multi-instrument deal

Biotage AB and Shanghai Chempartner Co., Ltd. sign multi-instrument deal

Shanghai Chempartner Co., Ltd., one of China's leading Contract Research
Organizations (CRO), has invested in Biotage SP automated flash instruments and
Initiator microwave synthesizers with delivery scheduled over the next 12
months. This is Biotages's largest single order in China at a value of SEK 10m. 


Biotage drug discovery instruments and consumables are widely used by medicinal
chemists at the world's leading pharmaceutical companies, and academic research
laboratories. Many multinational pharmaceutical firms, with a long history of
using Biotage equipment, have either built new research facilities in China or
are outsourcing projects to Chinese CROs.

Chempartner provides contract research services to leading multinational
pharmaceutical firms for rapid and cost effective production of compound
libraries, novel intermediates, and lead optimization. Located in Shanghai
Zhangjiang Hi-tech Park, Chempartner operates in four 210,000 sq. ft.
state-of-the-art laboratory facilities with over 650 synthetic workstations. 

Chempartner's CEO, Michael Hui, says “We have expanded our operations over the
last 4 years to accommodate the rapidly growing trend toward out-sourcing key
elements of the drug discovery process.  We need the most advanced tools
available to create complex new molecules quickly and at high quality.  Biotage
provides a complete suite of automated tools that improve our workflow and allow
our chemists to meet the high-standards of our clients; their instrument
performance and proven reliability along with their strong commitment to our
success were the key elements of our decision.” 

“China is the fastest growing market for pharmaceutical contract research.
Biotage has been successful in China and this commitment from Chempartner is a
strong confirmation of our strategy and focus on drug discovery tools. We will
continue to expand our relationships in China and work closely with Chempartner
to ensure their success as they implement our equipment and consumables into
their research programs." says Torben Jörgensen President and CEO of Biotage AB.

Contact:
Torben Jörgensen, President and CEO
Tel: +46 707 490 584, torben.jorgensen@eu.biotage.com 

About Biotage
Biotage is a global company active in life science research with strong
technologies, a broad range of operations and a long-term view of the market.
The company offers solutions, knowledge and experience in the areas of genetic
analysis and medicinal chemistry. Customers include the world's top 30
pharmaceutical companies, 20 largest biotech companies and leading academic
institutes. The company is headquartered in Uppsala and has offices in the US,
Japan, UK and several other European countries. Biotage has approximately 340
employees and sales of 519 MSEK in 2006. Biotage is listed on the Stockholm
stock exchange. Website: www.biotage.com


About Shanghai ChemPartner Co., Ltd.
Founded in 2003, Shanghai ChemPartner Co., Ltd. is an R&D contract research
company focused on providing customized services to international
pharmaceutical, biotech, agrochemical, and chemical companies.

ChemPartner currently has a team of more than 600 scientists, including more
than 100 PhDs, who either had extensive oveseas R&D experiences in
pharmaceutical / biotech companies, universities, or were trained at top
chemistry research institutes in China before joining ChemPartner. For more
information, please visit: www.chempartner.cn